AGP-100

N/A

Report date: 2025/12/05 20:00:50
NME

Base Information

Drug NameAGP-100
Drug Alias NameAGP100AGP-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 2A inhibitors
TargetsPhosphodiesterase 2A
Therapy Area/IndicationsTachycardia, Ventricular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAgiana Pharmaceuticals AS
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTachycardia, Ventricular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A